(Q35905069)

11 August 2017

title

Posttransplant lymphoma--a single-center experience of 500 liver transplantations (English)

1 reference

11 August 2017

main subject

liver transplantation

1 reference

Stefan Norin

1

1 reference

11 August 2017

Eva Kimby

2

1 reference

11 August 2017

Bo-Göran Ericzon

3

1 reference

11 August 2017

Birger Christensson

4

1 reference

11 August 2017

Birgitta Sander

5

1 reference

11 August 2017

Gunnar Söderdahl

6

1 reference

11 August 2017

Hans Hägglund

7

1 reference

11 August 2017

publication date

1 January 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

21

1 reference

11 August 2017

issue

3

1 reference

11 August 2017

page(s)

273-284

1 reference

https://scigraph.springernature.com/pub.10.1385/mo:21:3:273

11 August 2017

exact match

0 references

cites work

Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection

1 reference

12 December 2020

Durable remission after aggressive chemotherapy for very late post-kidney transplant lymphoproliferation: A report of 16 cases observed in a single center.

1 reference

12 December 2020

Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's sarcoma

1 reference

12 December 2020

Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication

1 reference

12 December 2020

Malignant lymphomas in transplantation patients

1 reference

12 December 2020

Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate

1 reference

12 December 2020

The role of adoptive immunotherapy in the prevention and treatment of lymphoproliferative disease following transplantation

1 reference

12 December 2020

Interferon and cytotoxic chemotherapy for the treatment of post-transplant lymphoproliferative disorder

1 reference

12 December 2020

Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients

1 reference

12 December 2020

Management and outcome of liver recipients with post-transplant lymphoproliferative disease

1 reference

12 December 2020

Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients

1 reference

12 December 2020

Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.

1 reference

12 December 2020

Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant

1 reference

12 December 2020

The changing pattern of posttransplant malignancies

1 reference

12 December 2020

Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients.

1 reference

12 December 2020

Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression

1 reference

12 December 2020

Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment

1 reference

12 December 2020

Outcome of PTLD in renal and liver allograft recipients

1 reference

12 December 2020

Simultaneous kidney-pancreas transplantation in a patient with small lymphocytic lymphoma.

1 reference

12 December 2020

Incidence and clinical characteristics of posttransplant lymphoproliferative disorders: report from a single center

1 reference

12 December 2020

Posttransplant lymphoproliferative disorders in renal allograft recipients: report of 53 cases of a French multicenter study. PTLD French Working Group

1 reference

12 December 2020

Rational management of posttransplant lymphoproliferative disorder in pediatric recipients

1 reference

12 December 2020

Anti-CD20 antibody (rituximab) administration in patients with late occurring lymphomas after solid organ transplant.

1 reference

12 December 2020

Cancer in immune-suppressed organ transplant recipients: aetiology and evolution

1 reference

12 December 2020

Aggressive treatment for postcardiac transplant lymphoproliferation

1 reference

12 December 2020

Successful outcome of orthotopic liver transplantation in patients with preexisting malignant states

1 reference

12 December 2020

Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells

1 reference

12 December 2020

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

12 December 2020

Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients

1 reference

12 December 2020

Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases

1 reference

12 December 2020

Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients

1 reference

12 December 2020

Identifiers

DOI

10.1385/MO:21:3:273

1 reference

Dimensions Publication ID

11 August 2017

1045878826

0 references

1 reference